KROS Market Cap & Key Metrics
Keros Therapeutics, Inc.
$11.95
+$0.31(+2.66%)
56
Overall
80
Value
45
Tech
44
Quality
Market Cap
$230.79M
Volume
194.16K
52W Range
$9.69 - $22.55
Target Price
$18.86
KROS market cap is $230.79M. This page lists Keros Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
KROS Key Metrics
- Market cap
- $230.79M
- EPS estimate, current year
- $-5.27
- EPS growth, 3-year
- +36.87%
- Value score
- 80
- Quality score
- 44
- Technical score
- 45
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $244.06M | $3.55M | $151.0K | - | $20.10M |
| EBITDA | $95.82M | -$184.00M | -$150.63M | -$103.06M | -$56.35M |
| EPS | $2.34 | $-5.00 | $-5.20 | $-4.15 | $-2.52 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $11.95 | +2.7% | 194.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Keros Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW